Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

67.34
Delayed Data
As of 4:01pm ET
 0.00 / 0.00%
Today’s Change
50.90
Today|||52-Week Range
125.35
-9.77%
Year-to-Date
Mallinckrodt (MNK) Q3 Earnings: Will the Stock Surprise?
Jul 27 / Zacks.com - Paid Partner Content
4 Low P/CF Stocks to Improve Your Value Investing
Jul 22 / Zacks.com - Paid Partner Content
5 Low Price-to-Book Stocks with Great Growth Prospects
Jul 26 / Zacks.com - Paid Partner Content
Research Reports for Amazon, IBM, Cisco & others
Jul 19 / Zacks.com - Paid Partner Content
Siegfried Holdings, Held by Tweedy Browne, Way Undervalued
Jul 22 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close67.34
Today’s open67.22
Day’s range66.76 - 68.47
Volume1,375,132
Average volume (3 months)1,900,254
Market cap$7.4B
Dividend yield--
Data as of 4:01pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+12.40%
Earnings growth (next 5 years)+9.47%
Revenue growth (last year)+31.75%
P/E ratio20.4
Price/Sales2.40
Price/Book1.49

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...+0.04+0.09%
ALKSAlkermes Plc+1.77+3.68%
VRXValeant Pharmaceutic...-0.83-3.59%
SGENSeattle Genetics Inc+0.69+1.46%
Data as of 4:08pm ET, 07/29/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$2.00
Annual revenue (last year)$3.3B
Annual profit (last year)$322.1M
Net profit margin9.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts

Partner Offers

Search for Jobs